MeadowBrook Investment Advisors’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,280
Closed -$218K 303
2024
Q4
$218K Buy
10,280
+1,460
+17% +$38.3K 0.19% 104
2024
Q3
$284K Sell
8,820
-3,500
-28% -$103K 0.26% 83
2024
Q2
$293K Buy
12,320
+1,690
+16% +$43.4K 0.28% 81
2024
Q1
$317K Buy
10,630
+500
+5% +$15.6K 0.3% 81
2023
Q4
$324K Buy
+10,130
New +$294K 0.31% 74

Other funds holding SGRY

MeadowBrook Investment Advisors's SGRY Position: Q1 2025 in Review

MeadowBrook Investment Advisors sold out of Surgery Partners (SGRY) in Q1 2025, closing a stake of 10,280 shares — an estimated $218K sold.

MeadowBrook Investment Advisors first reported a position in SGRY in Q4 2023 and held it in 5 quarters. The position peaked at $324K in Q4 2023. 208 funds tracked by Wall St. Rank hold SGRY as of Q1 2025.

  • MeadowBrook Investment Advisors reported no remaining Surgery Partners position as of Q1 2025 after selling out during the quarter.
  • MeadowBrook Investment Advisors sold 10,280 Surgery Partners shares in Q1 2025, an estimated $218K.
  • MeadowBrook Investment Advisors first reported a position in Surgery Partners in Q4 2023 and held it in 5 quarters.
  • MeadowBrook Investment Advisors's Surgery Partners position peaked at $324K in Q4 2023.
  • 208 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2025.

Based on MeadowBrook Investment Advisors's 13F filing for Q1 2025, filed 30 Apr 2025.